112.98
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $112.98, with a volume of 1.70M.
It is down -1.07% in the last 24 hours and down -9.41% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$114.20
Open:
$115.89
24h Volume:
1.70M
Relative Volume:
0.76
Market Cap:
$31.93B
Revenue:
$7.07B
Net Income/Loss:
$1.29B
P/E Ratio:
24.91
EPS:
4.5355
Net Cash Flow:
$993.00M
1W Performance:
+1.33%
1M Performance:
-9.41%
6M Performance:
-7.31%
1Y Performance:
-6.25%
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Aug Weekly: Will Agilent Technologies Inc benefit from current market trends2026 Big Picture & Momentum Based Trading Signals - baoquankhu1.vn
Pensionfund Sabic Buys New Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) latest stock news and headlines - Yahoo Finance Singapore
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting lab effic - AD HOC NEWS
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting life scie - AD HOC NEWS
Bullish Move: Sue Rataj Shows Confidence, Acquires $241K In Agilent Technologies Stock - Benzinga
Agilent Technologies (A) to Acquire Biocare Medical for $950M - Insider Monkey
Agilent Technologies Faces Mixed Technical Signals Amid Valuation Adjustments - Markets Mojo
SG Americas Securities LLC Has $109.97 Million Position in Agilent Technologies, Inc. $A - MarketBeat
A SEC FilingsAgilent Technologies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Agilent Technologies (A) Announces Amendments to Corporate Gover - GuruFocus
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A - Moomoo
Agilent, Axion End Cell Analysis IP Suit After Jury Selection - Law360
Agilent Technologies Launches Advanced Chromatography Solutions Enhancing Precision in Drug Developm - AD HOC NEWS
Agilent (NYSE: A) director granted 2,158 fully vested common shares - Stock Titan
Agilent (NYSE: A) director Otis Brawley granted vested stock awards - Stock Titan
Director George Scangos gets 3,215 Agilent (NYSE: A) shares - Stock Titan
Director at Agilent (NYSE: A) gets stock grant, surrenders shares for tax - Stock Titan
Agilent (NYSE: A) director Wilson Dow reports fully vested stock grant - Stock Titan
Agilent (NYSE: A) director receives 2,158-share stock award, defers receipt - Stock Titan
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Director KOH BOON HWEE - Moomoo
Agilent (NYSE: A) director granted shares and withholds stock for taxes - Stock Titan
Agilent (NYSE: A) director granted 2,158 fully vested shares, holds 7,138 - Stock Titan
Agilent (NYSE: A) director Judy Brown granted 2,158 fully vested shares - Stock Titan
Agilent (NYSE: A) director Mala Anand granted 2,158 fully vested shares - Stock Titan
Agilent, Axion Nix Patent Trial, Pause Cases as They Near Deal - Bloomberg Law News
Agilent Technologies, Inc. (A) Stock Price, News, Quote & History - Yahoo Finance
Nordea Investment Management AB Sells 106,321 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech Efficiency in 2026 - AD HOC NEWS
Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech in 2026 - AD HOC NEWS
Agilent Q1 earnings miss estimates, revenues up Y/Y, shares fall - MSN
Agilent, Danaher could be potential buyers of Qiagenanalyst - MSN
Agilent Technologies Powers Art Conservation Workshop at Yale University - Yahoo
Agilent’s USCAP 2026 Pathology Updates Deepen Oncology Diagnostics Narrative - Sahm
Dividend Watch: Whats the beta of Agilent Technologies Inc stockMarket Sentiment Review & Reliable Entry Point Alerts - baoquankhu1.vn
Agilent Shareholders Approve Board Declassification and Governance Changes - TipRanks
Agilent (NYSE: A) holders back board declassification and pay votes - Stock Titan
Agilent Debuts Future of the Automated Laboratory at Korea Lab 2026 - marketscreener.com
AIA Group Ltd Invests $2.48 Million in Agilent Technologies, Inc. $A - MarketBeat
Aug PostEarnings: Is Agilent Technologies Inc showing insider buyingQuarterly Portfolio Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026 - BioSpace
Agilent G4513A Injector Tower Drives GC/MS Precision in Latest LabRulez 2026 Applications - AD HOC NEWS
Danske Bank A S Takes $51.53 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Axion Cleared Of False Advertising Before Agilent Patent Trial - Law360
Agilent's Wide Moat Appears Intact in Its Life Science, Diagnostic, and Applied End Markets - Morningstar
Is It Time To Reassess Agilent Technologies (A) After Its Recent Share Price Weakness - Yahoo Finance
Agilent Technologies FQ3 2025 Earnings Preview - MSN
Agilent’s $950m Biocare buy: The ‘aligned’ asset for pathology innovation - BioXconomy
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):